Results 171 to 180 of about 592,523 (331)

Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Breast milk is the optimal infant nutrition; however, many infants may be exposed to prescription drugs if used by their mothers during breastfeeding. The aim of this study was to evaluate the prevalence and patterns of prescription drug use among breastfeeding mothers and to assess the availability of relative infant dose information for
Ditte Resendal Gotfredsen   +5 more
wiley   +1 more source

The use of mass spectrometry in obstetric and gynecology

open access: yesOpen Chemistry, 2013
Ilia Gheorghe   +4 more
doaj   +1 more source

Enhanced Recovery after Surgery in Gynecology: A Review of the Literature.

open access: yesJournal of minimally invasive gynecology, 2019
S. Scheib, M. Thomassee, J. Kenner
semanticscholar   +1 more source

A Gynecological Case [PDF]

open access: green, 1890
W. S. EVERETT
openalex   +1 more source

EpCAM and CD24 specific EVRNA analysis for ovarian cancer diagnosis

open access: yesBulletin of the Korean Chemical Society, EarlyView.
We developed a sensitive EV analysis technique by combination of immunomagnetic enrichment of tumor‐derived EVs with miRNA analysis. This technique offers over 88% diagnostic accuracy of ovarian cancer using only a single miRNA marker analysis of plasma EVs.
Yejin Kim   +11 more
wiley   +1 more source

Colpocleisis for recurrent pelvic organ prolapse after tension-free vaginal mesh repair: a case report. [PDF]

open access: yesJ Surg Case Rep
Misawa A   +7 more
europepmc   +1 more source

A phase II basket trial of dual anti‐CTLA‐4 and anti‐PD‐1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

open access: yesCancer Communications, EarlyView.
Abstract Background The combined use of anti‐programmed cell death protein 1 (PD‐1)/anti‐cytotoxic T‐lymphocyte associated protein 4 (CTLA‐4) checkpoint inhibitors has been effective in various cancer types. The Southwest Oncology Group (SWOG) Dual Anti‐CTLA‐4 and Anti‐PD‐1 Blockade in Rare Tumors (DART) S1609 study investigated ipilimumab and ...
Young Kwang Chae   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy